@IdVilchez @wfwrighID @DrToddLee @DrEmilyMcD @Cortes_Penfield @SAIRABT @BradSpellberg @FungalDoc @GermHunterMD @Boghuma @AntibioticDoc Great question & debatable. We worked on 2 meta of RCTs & found benefit in clinical cure (& mortality? but no
RT @khalideljaaly: Our 2017 meta-analysis of RCTs https://t.co/pffqeMT5CB found higher clinical failure in regimens lacking this activity b…
Our 2017 meta-analysis of RCTs https://t.co/pffqeMT5CB found higher clinical failure in regimens lacking this activity but we included any CAP patients regardless of isolated organisms. So, it was not clear if the benefit was due to activity against atypic
@TomWalshMD13 @JustinJWChoi @ABsteward @BradSpellberg Our meta-analysis of RCTs found a significant benefit in clinical cure with empiric atypical regimens, but it did not achieve statistical significance with mortality. Debatable topic 🤷🏽♂️ https://t.co/
@alishehri1400 @Ahmad_Odadi @ABsteward @accpinfdprn @ESCMID @WesKufel @blandman19 @ASPphysician @TimbrookTT @IDstewardship @IDSAInfo @accpchest @DrToddLee @khalid_eljaaly2 Thanks for tagging. Our meta: https://t.co/pffqeMT5CB It was not discussed. However,
RT @Saudi_Pharma: Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneum…
RT @khalideljaaly: @Cortes_Penfield Great point👍🏽 I wish we do not have to cover atypical👾 but cannot recommend that yet. Analysis of FOCUS…
RT @khalideljaaly: @Cortes_Penfield Great point👍🏽 I wish we do not have to cover atypical👾 but cannot recommend that yet. Analysis of FOCUS…
@Cortes_Penfield Great point👍🏽 I wish we do not have to cover atypical👾 but cannot recommend that yet. Analysis of FOCUS trials https://t.co/dnGj1Chx1m plus our recent meta found a benefit https://t.co/pffqeMT5CB. Not sure if anti-inflammatory effect has a
RT @CIDRAP_ASP: Clinical failure w/ and w/o empiric atypical bacteria coverage in hosp. adults with CAP - from @khalideljaaly et al https:/…
RT @CIDRAP_ASP: Clinical failure w/ and w/o empiric atypical bacteria coverage in hosp. adults with CAP - from @khalideljaaly et al https:/…
RT @ph_tws: #أبحاث_الصيادلة https://t.co/htD7FERU4R للباحث د.خالد الجعلي @khalid_eljaaly2
RT @khalideljaaly: 📢Our meta-analysis showed 15% reduction⬇️ in clinical failure with empiric atypical bacterial👾 coverage @BMC_series http…
RT @CIDRAP_ASP: Clinical failure w/ and w/o empiric atypical bacteria coverage in hosp. adults with CAP - from @khalideljaaly et al https:/…
RT @SaudiMDresearch: رابط البحث: https://t.co/CUfymuZgjO #ابحاث_طبيه_سعوديه
RT @SaudiMDresearch: رابط البحث: https://t.co/CUfymuZgjO #ابحاث_طبيه_سعوديه
RT @SaudiMDresearch: رابط البحث: https://t.co/CUfymuZgjO #ابحاث_طبيه_سعوديه
RT @SaudiMDresearch: رابط البحث: https://t.co/CUfymuZgjO #ابحاث_طبيه_سعوديه
RT @SaudiMDresearch: رابط البحث: https://t.co/CUfymuZgjO #ابحاث_طبيه_سعوديه
RT @CIDRAP_ASP: Clinical failure w/ and w/o empiric atypical bacteria coverage in hosp. adults with CAP - from @khalideljaaly et al https:/…
RT @khalideljaaly: Great experience with @BioMedCentral infectious disease so far.Feel free to ask questions about our new metaanalysis htt…
RT @khalideljaaly: 📢Our meta-analysis showed 15% reduction⬇️ in clinical failure with empiric atypical bacterial👾 coverage @BMC_series http…
Great experience with @BioMedCentral infectious disease so far.Feel free to ask questions about our new metaanalysis https://t.co/i1d8HyMGmq
RT @BIOCIENCIA2013: Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with c... https://t.co/ZfOp…
RT @Pro_antibiotic: "Clinical failure with and without atypical bacteria coverage in community-acquired pneumonia: meta-analysis" https://t…
RT @BIOCIENCIA2013: Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with c... https://t.co/ZfOp…
RT @BIOCIENCIA2013: Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with c... https://t.co/ZfOp…
RT @Pro_antibiotic: "Clinical failure with and without atypical bacteria coverage in community-acquired pneumonia: meta-analysis" https://t…
RT @Pro_antibiotic: "Clinical failure with and without atypical bacteria coverage in community-acquired pneumonia: meta-analysis" https://t…
RT @Pro_antibiotic: "Clinical failure with and without atypical bacteria coverage in community-acquired pneumonia: meta-analysis" https://t…
RT @Pro_antibiotic: "Clinical failure with and without atypical bacteria coverage in community-acquired pneumonia: meta-analysis" https://t…
RT @CIDRAP_ASP: Clinical failure w/ and w/o empiric atypical bacteria coverage in hosp. adults with CAP - from @khalideljaaly et al https:/…
RT @Pro_antibiotic: "Clinical failure with and without atypical bacteria coverage in community-acquired pneumonia: meta-analysis" https://t…
RT @Pro_antibiotic: "Clinical failure with and without atypical bacteria coverage in community-acquired pneumonia: meta-analysis" https://t…
RT @CIDRAP_ASP: Clinical failure w/ and w/o empiric atypical bacteria coverage in hosp. adults with CAP - from @khalideljaaly et al https:/…
RT @Pro_antibiotic: "Clinical failure with and without atypical bacteria coverage in community-acquired pneumonia: meta-analysis" https://t…
"Clinical failure with and without atypical bacteria coverage in community-acquired pneumonia: meta-analysis" https://t.co/x3GcgnJJja
Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with c... https://t.co/ZfOpCPSzrS #bmcinfectdis
RT @CIDRAP_ASP: Clinical failure w/ and w/o empiric atypical bacteria coverage in hosp. adults with CAP - from @khalideljaaly et al https:/…
RT @CIDRAP_ASP: Clinical failure w/ and w/o empiric atypical bacteria coverage in hosp. adults with CAP - from @khalideljaaly et al https:/…
Clinical failure w/ and w/o empiric atypical bacteria coverage in hosp. adults with CAP - from @khalideljaaly et al https://t.co/sXydCpOy8Q
RT @khalideljaaly: Check out our first published meta-analysis if you missed it👾💊 https://t.co/i1d8HyMGmq
RT @khalideljaaly: 📢Our meta-analysis showed 15% reduction⬇️ in clinical failure with empiric atypical bacterial👾 coverage @BMC_series http…
RT @khalideljaaly: 📢Our meta-analysis showed 15% reduction⬇️ in clinical failure with empiric atypical bacterial👾 coverage @BMC_series http…
RT @khalideljaaly: 📢Our meta-analysis showed 15% reduction⬇️ in clinical failure with empiric atypical bacterial👾 coverage @BMC_series http…
RT @khalideljaaly: Check out our first published meta-analysis if you missed it👾💊 https://t.co/i1d8HyMGmq
Check out our first published meta-analysis if you missed it👾💊 https://t.co/i1d8HyMGmq
RT @khalideljaaly: 📢Our meta-analysis showed 15% reduction⬇️ in clinical failure with empiric atypical bacterial👾 coverage @BMC_series http…
RT @khalideljaaly: 📢Our meta-analysis showed 15% reduction⬇️ in clinical failure with empiric atypical bacterial👾 coverage @BMC_series http…
📢Our meta-analysis showed 15% reduction⬇️ in clinical failure with empiric atypical bacterial👾 coverage @BMC_series https://t.co/YyZSp4LxSo